GeneDx (NASDAQ:WGS) was upgraded to Buy from Hold at Jefferies banking on the company's growth outlook following meetings with management in London.
Despite a rocky start to the year, including a Q1 volume miss, analysts at Jefferies now see a clear path to recovery driven by strong growth in neonatal intensive care unit testing, new clinical indications, and improving cost efficiency.
"Of course, it will take time to rebuild credibility, but reset valuation is compelling for one of the better growth stories in diagnostics with no competition," Tycho Peterson, analyst at Jefferies said.
New Jersey's Newark Liberty International Airport (EWR) has again been thrown into turbulence. Earlier, air traffic control radar screens briefly went dark—for the second time in weeks—and now the Federal Aviation Administration (FAA) has issued a ground stop due to ongoing runway construction. It's yet another confidence blow for travelers.
ABC News reports that radar systems operated by air traffic controllers at EWR experienced a brief outage around 0355ET:
Air traffic controllers could be heard telling a FedEx plane that their screens went dark and then asking the aircraft to tell their company to put pressure on to get the problem fixed.
In another transmission, a controller told an arriving private jet that the airport just had a brief radar outage and to stay at or above 3,000 feet in case the controllers couldn't get in touch during the aircraft's descent.
ABC noted this was the second ATC computer outage in a week:
Last week, an outage at Newark caused ATC computer screens to go dark for roughly 60 to 90 seconds and prevented controllers from talking to aircraft during that time, according to multiple sources with knowledge of the incident. As a result, the Federal Aviation Administration briefly halted all departures to the airport.
Hours later, around 1000 ET, reports hit the wires that the FAA issued a ground stop at EWR because of runway construction, staffing shortages, and equipment troubles, according to local media outlet PIX11.
The flight-tracking website FlightAware shows that EWR has about 100 flights delayed so far this morning.
On Thursday afternoon, former ABC and Fox News anchor John Stossel released a video calling Newark Airport a "disaster," arguing that air traffic control should be taken out of the hands of the bloated federal government and handed over to private companies instead.
Also on Thursday, Transportation Secretary Sean Duffy announced new, "state-of-the-art" ATC systems will replace "antiquated" ones...
Why didn't the Biden administration focus on upgrading America's flight radars and ATC systems? They were too focused on toxic DEI and discussing how to identify a woman.
Kari Lake, a former Arizona gubernatorial candidate and senior adviser to USAGM, unveiled the agreement in a May 6 statement, calling the OAN deal a taxpayer win. Under the deal, OAN will provide its video and news feed to USAGM’s networks—including Voice of America (VOA), Radio MartÃ, and the Office of Cuba Broadcasting—free of charge.
“This is an enormous benefit to the American taxpayer, who is the sole source of funding for USAGM’s news outlets, which broadcast only to international audiences,” Lake said, adding that she’s “grateful for their generosity.”
Lake said the idea originated with the Office of Cuba Broadcasting, which proposed OAN as a content partner for its Miami-based broadcasts to Cuba. After Lake reached out, OAN agreed to provide its English-language content at no cost.
Although Lake currently holds no editorial authority over VOA or Office of Cuba Broadcasting programming, she said the arrangement expands the range of news content available to agency journalists.
“In my current role as Senior Advisor to USAGM, I don’t have editorial control over the content of VOA and OCB programming, but I can ensure our outlets have reliable and credible options as they work to craft their reporting and news programs,” she said. “And every day, I look for ways to save American taxpayers money. Bringing in OAN as a video/news source does both.”
The content deal comes amid a sweeping overhaul of USAGM under President Donald Trump’s second-term plan to shrink the federal government and dismantle what he describes as wasteful agencies. A March executive order identified USAGM as one of eight federal entities slated for elimination or radical downsizing, directing agency heads to wind down all non-legally required functions.
In response, USAGM placed over 1,000 employees on leave and informed some 600 contractors their roles would be terminated as broadcasts were paused. The agency also began terminating contracts with major wire services—including The Associated Press, Reuters, and Agence France-Presse—which Lake called “expensive and unnecessary.”
“With a nearly billion-dollar budget, we should be producing news ourselves,” Lake said at the time. “If that’s not possible, the American taxpayer should demand to know why.”
Lake estimated the move would save $53 million annually and signaled a broader review of agency expenditures, saying she had discovered “a lot of nonsense that the American taxpayer should not be paying for.”
The reorganization has drawn sharp pushback from some VOA journalists and advocates. Two VOA staffers, White House bureau chief Patsy Widakuswara and press freedom editor Jessica Jerreat, are among several employees suing the Trump administration over its handling of the agency.
The two criticized the OAN content deal, saying it could undermine VOA’s credibility and editorial independence.
“Congress mandated VOA to report reliable and authoritative news, not to outsource its journalism to outlets aligned with the president’s agenda,” they said in a statement. “VOA already has talented and professional journalists ready to tell America’s story in line with the VOA Charter, but we are blocked from our own newsroom.”
Trump, who has frequently attacked public broadcasters such as NPR and PBS, has long viewed VOA as a source of liberal bias. In a March statement supporting the executive order to defund USAGM, the White House labeled VOA “The Voice of Radical America,” and declared that “taxpayers are no longer on the hook for radical propaganda.”
Democrats on the House Foreign Affairs Committee also criticized the OAN deal and the Trump administration’s characterization of VOA.
“The Trump administration smeared VOA and USAGM as radical and biased to justify gutting it. Now Kari Lake wants to repurpose VOA as a megaphone for OAN—a far-right, pro-Trump propaganda outlet,” they wrote in a post on X. “VOA was built to fight propaganda—not broadcast it.”
Meanwhile, a federal judge last month ordered the Trump administration to reinstate VOA employees, and an appeals court quickly blocked the ruling, finding that the lower court lacked the authority to intervene.
Launched in 2013, OAN is a family-owned media outlet known for its conservative perspectives.
Organogenesis Holdings (NASDAQ:ORGO) reported its financial results for Q1 2025, revealing a significant decline in revenue and an unexpected operating loss. The company’s stock took a sharp downturn in aftermarket trading, dropping by 18.54% to $4.35. Despite maintaining its full-year revenue guidance, the market reacted negatively to the earnings miss and challenging market conditions. The recent decline comes amid an otherwise strong year for the stock, which has delivered a 67% year-to-date return
Q1 2025 net revenue decreased by 21% year-over-year to $86.7 million.
The company reported an operating loss of $26.7 million, up from a $3.9 million loss in Q1 2024.
Stock price fell by 18.54% in aftermarket trading, reflecting investor concerns.
Organogenesis reaffirmed its full-year 2025 revenue guidance of $480-$535 million.
Market uncertainty persists due to delayed LCD implementation.
On May 7, 2025, Asit Parikh, a Director at Phathom Pharmaceuticals Inc (PHAT, Financial), purchased 10,000 shares of the company. Following this transaction, the insider now holds a total of 95,500 shares. The purchase was documented in a SEC Filing. Phathom Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases. The company's mission is to address unmet needs in the gastrointestinal space with innovative therapies. The recent acquisition by the insider is part of a broader trend observed over the past year, where the insider has purchased a total of 30,000 shares and has not sold any shares. This activity is set against a backdrop of 4 insider buys and 9 insider sells within the company over the same period. Shares of Phathom Pharmaceuticals Inc were trading at $2.5 each on the day of the insider's purchase, resulting in a market cap of $159.874 million for the company.
SNN Network, The Official Small-, Micro- and Nano-Cap News Source™, today published a new Video Interview with the team from Regencell Bioscience Holdings Limited (NASDAQ:RGC), including: Jay Lee, CEO of Regencell Bioscience Asia Limited, and Paul Niewiadomski, Independent Director. Regencell is an early-stage bioscience company focuses on the research, development and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, as well as infectious diseases affecting people's immune system, according to the company's website (see here:www.regencellbioscience.com).
Click the following link to watch the Video Interview:
Regencell Bioscience Holdings Limited is an early-stage bioscience company that commenced operations in Hong Kong is 2014. Regencell focuses on the research, development and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune system such as COVID. Regencell has completed its first research study using personalized TCM formula for the treatment of ADHD and ASD in Hong Kong and aims to launch three liquid-based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients initially in Hong Kong and subsequently to other markets as it deems appropriate. The Company formed a joint venture to offer COVID related treatments to patients in ASEAN countries, India, Japan, Australia and New Zealand.
